Neoadjuvant therapy for gastrointestinal stromal tumor

Molecular-targeting therapy using tyrosine kinase inhibitor imatinib mesylate is effective for metastasis/recurrent gastrointestinal stromal tumors (GISTs). Likewise, imatinib would be effective in the neoadjuvant therapy for high-risk GIST. Neoadjuvant therapy may have the potential to increase the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Transl Gastroenterol Hepatol
Egile Nagusiak: Ishikawa, Takashi, Kanda, Tatsuo, Kameyama, Hitoshi, Wakai, Toshifumi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AME Publishing Company 2018
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5803029/
https://ncbi.nlm.nih.gov/pubmed/29441368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2018.01.01
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak